We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Field ECGs Improve Time-to-Treatment Balloon Time

By HospiMedica International staff writers
Posted on 04 Feb 2010
A new study has found that heart attack victims who undergo electrocardiograms (ECGs) in the field experience significantly reduced time-to-treatment or door-to-balloon (D2B) time.

Researchers at Providence Hospital and Medical Center (Southfield, MI, ISA) conducted a prospective, observational study of D2B time in three hospitals in Southeast Michigan (USA) from October 1, 2003 through April 30, 2008. More...
At each center, a protocol was initiated where emergency medical services (EMS) personnel obtained a 12-lead ECG during initial assessment in the field from patients with symptoms suggestive of ST segment elevation myocardial infarction (STEMI). The prehospital ECG data was transmitted via cellular link to an emergency room (ER) computer receiving station where physicians interpreted the information and upon diagnosis of STEMI, and activated the cardiac catheterization laboratory (CCL) team prior to the patient's arrival. Similar data were collected for all patients who came to the ER without prehospital ECGs (the control group). Baseline characteristics including cardiac risk factors were similar between the groups.

The results showed that 241 patients with STEMI received in-hospital ECGs and 108 patients received prehospital ECGs. In-hospital mortality was 2% for the control group (7 out 241) compared with no deaths in those patients with prehospital ECG. Patients in the in-hospital ECG group who presented during working hours waited 75 minutes prior to reperfusion treatment, while those presenting during off-hours (weekends and holidays) experienced a 98-minute wait time. In the prehospital ECG group there was a significant reduction in D2B time independent of presentation time, with 98% of patients in this group who were admitted during off-hours having treatment within 90 minutes. The study was published in the January 2010 issue of Catheterization and Cardiovascular Interventions.

"Our results reemphasize the importance of early activation of the CCL in order to improve time-to-reperfusion in patients with STEMI,” said lead author cardiologist Shukri David, M.D., section chief of cardiology at Providence Hospital.

STEMI occurs when a blood clot totally obstructs a coronary artery, and is treated with reperfusion therapy to reestablish blood flow as quickly as possible. Prior studies have shown that rapid D2B with angioplasty was associated with lower mortality rates and that for each 30 minutes of delay, the relative risk of 1-year mortality increases by 7.5%. In an effort to improve patient survival rates, the American College of Cardiology (ACC, Washington, DC, USA) and the American Heart Association (AHA, Dallas, TX, USA) developed U.S. national guidelines that state hospitals treating STEMI patients should strive to achieve a median D2B time of less than 90 minutes.

Related Links:
Providence Hospital and Medical Center
American College of Cardiology
American Heart Association



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.